compound tirzepatide vs mounjaro Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks Compounded Tirzepatide vs Mounjaro: Clinical

Through a blend of clinical study findings, expert opinions, and guideline reviews, we aim to equip healthcare professionals and patients with the knowledge necessary to navigate the complexities of managing coexisting conditions with these medications

Key stat: GLP-1 medications accounted for $360.9 million, or 35.7%, of the top 10 prescription linear TV ad spending in H1 2025, according to a July iSpot.tv report

For instance, there is a black box warning, the most serious kind from the FDA, on both medications for the risk of a certain rare type of thyroid cancer

Among the most well-known today are GLP-1 receptor agonists, medications like semaglutide and tirzepatide that have been shown to help patients lose a significant percentage of body weight

New Research: Muscle Loss and Metabolic Impact A July 2025 study presented at ENDO 2025 and covered by ScienceDaily found that women on GLP-1 drugs like Ozempic may lose up to 40% of their weight from muscle mass, not just fat

O.Duran-OrtizS.KopchickJ